
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Sponsored
Sponsored
2026-07-15RGNT6-KRegentis Biomaterials Ltd. Receives European Regulatory Approval for New GelrinC Manufacturing ProcessHIGH
Regentis Biomaterials Ltd. announced that it has received approval from the European Notified Body for its next-generation, solvent-free manufacturing process for GelrinC®. This new process increases production yield by 400%, five-fold, while improving manufacturing efficiency, scalability, and safety. The approval com...
Medical Instruments & Suppliesoperation_related
Sponsored
2026-07-15SVA6-KSinovac Extends Submission Deadline for $55.00 Special Cash Dividend to December 2026MEDIUM
On July 15, 2026, Sinovac Biotech Ltd. (NASDAQ: SVA) announced a second extension for the deadline to submit payment instructions regarding its previously declared special cash dividend. The special dividend of $55.00 per common share is payable to shareholders of record as of May 23, 2025. Originally, the company requ...
BiotechnologyOthers